Tudor Investment Corp
PTX

Tudor Investment Corp’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Tudor Investment Corp’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,580
Closed -$97K – 1888
2016
Q2 		$97K Buy
+21,580
New +$141K ﹤0.01% 1519
2016
Q1 		– Sell
-1,613
Closed -$48K – 2123
2015
Q4 		$48K Buy
+1,613
New +$48.8K ﹤0.01% 1584
2015
Q3 		– Sell
-7,580
Closed -$449K – 1886
2015
Q2 		$449K Buy
7,580
+2,630
+53% +$186K 0.01% 841
2015
Q1 		$529K Buy
+4,950
New +$472K 0.02% 704

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Tudor Investment Corp's PTX Position: Q3 2016 in Review

Tudor Investment Corp sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 21,580 shares — an estimated $97K sold.

Tudor Investment Corp first reported a position in PTX in Q1 2015 and held it in 4 quarters. The position peaked at $529K in Q1 2015. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • Tudor Investment Corp reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 21,580 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $97K.
  • Tudor Investment Corp first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 4 quarters.
  • Tudor Investment Corp's Pernix Therapeutics Holdings, Inc. position peaked at $529K in Q1 2015.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on Tudor Investment Corp's 13F filing for Q3 2016, filed 14 Nov 2016.